Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
DGX Stock Chart & Stats
$179.62
-$0.03(-0.02%)
At close: 4:00 PM EST
$179.62
-$0.03(-0.02%)
Day’s Range― - ―
52-Week Range$148.70 - $197.55
Previous CloseN/A
Volume143.08K
Average Volume (3M)1.10M
Market Cap
$20.30B
Enterprise Value$27.60B
Total Cash (Recent Filing)$432.00M
Total Debt (Recent Filing)$6.38B
Price to Earnings (P/E)21.4
Beta0.15
Next Earnings
Jan 29, 2026EPS Estimate
2.36Next Dividend Ex-Date
Jan 13, 2026Dividend Yield1.73%
Share Statistics
EPS (TTM)2.60
Shares Outstanding111,242,360
10 Day Avg. Volume993,564
30 Day Avg. Volume1,099,439
Financial Highlights & Ratios
PEG Ratio6.95
Price to Book (P/B)2.47
Price to Sales (P/S)1.70
P/FCF Ratio18.42
Enterprise Value/Market Cap1.36
Enterprise Value/Revenue2.54
Enterprise Value/Gross Profit7.64
Enterprise Value/Ebitda12.91
Forecast
1Y Price Target
$200.78Price Target Upside11.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)9.81
Revenue Forecast (FY)$10.98B
Bulls Say, Bears Say
Bulls Say
Consumer Channel GrowthQuest Diagnostics continues to benefit from improving mix, with growing upside from the consumer channel where DGX's own efforts are being complemented by partnerships with leading consumer health companies.
Financial PerformanceQuest delivered a strong quarter with revenue and earnings both ahead of consensus.
Guidance And Management CommentaryGuidance was raised, and management commentary was positive regarding utilization trends and margin expansion potential.
Bears Say
Margin ImpactMargins were impacted by elevated employee health care costs by around 40-50bp, in the quarter.
Stock PerformanceShares traded down 3% due to a rotation to other areas of healthcare, not because of Quest's results.
Quest Diagnostics News
DGX FAQ
What was Quest Diagnostics’s price range in the past 12 months?
Quest Diagnostics lowest stock price was $148.70 and its highest was $197.55 in the past 12 months.
What is Quest Diagnostics’s market cap?
Quest Diagnostics’s market cap is $20.30B.
When is Quest Diagnostics’s upcoming earnings report date?
Quest Diagnostics’s upcoming earnings report date is Jan 29, 2026 which is in 50 days.
How were Quest Diagnostics’s earnings last quarter?
Quest Diagnostics released its earnings results on Oct 21, 2025. The company reported $2.6 earnings per share for the quarter, beating the consensus estimate of $2.503 by $0.097.
Is Quest Diagnostics overvalued?
According to Wall Street analysts Quest Diagnostics’s price is currently Undervalued.
Does Quest Diagnostics pay dividends?
Quest Diagnostics pays a Quarterly dividend of $0.8 which represents an annual dividend yield of 1.73%. See more information on Quest Diagnostics dividends here
What is Quest Diagnostics’s EPS estimate?
Quest Diagnostics’s EPS estimate is 2.36.
How many shares outstanding does Quest Diagnostics have?
Quest Diagnostics has 111,242,360 shares outstanding.
What happened to Quest Diagnostics’s price movement after its last earnings report?
Quest Diagnostics reported an EPS of $2.6 in its last earnings report, beating expectations of $2.503. Following the earnings report the stock price went down -3.03%.
Which hedge fund is a major shareholder of Quest Diagnostics?
Currently, no hedge funds are holding shares in DGX
Quest Diagnostics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$200.78 (11.78% Upside)
$200.78 (11.78% Upside)
Blogger Sentiment
Bullish
DGX Sentiment 66%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 867.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $510.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.73%
12-Months-Change
Fundamentals
Return on Equity
13.69%
Trailing 12-Months
Asset Growth
0.63%
Trailing 12-Months
Company Description
Quest Diagnostics
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
DGX Company Deck
DGX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects strong performance in revenue growth, successful collaborations, and advances in diagnostics. However, the potential impact of PAMA reforms and higher operational costs present challenges.View all DGX earnings summariesDGX Revenue Breakdown
97.39% Diagnostic Information Services
2.61% All other operating segments
DGX Stock 12 Month Forecast
Average Price Target
$200.78
▲(11.78% Upside)
Technical Analysis
Ownership Overview
0.42% Insiders
32.42% Mutual Funds
15.37% Other Institutional Investors
23.79% Public Companies and
Individual Investors